Vedanta's planned demerger faces objections from SEBI and the government, delaying the process. The NCLT has deferred hearings to September 17, creating uncertainty for investors. The stock fell nearly 3% to ₹438 on the BSE, reflecting concerns over compliance and approvals. The outcome will be closely watched as Vedanta navigates regulatory scrutiny.